NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $0.74 -0.01 (-1.47%) As of 08/26/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Envoy Medical Stock (NASDAQ:COCH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Envoy Medical alerts:Sign Up Key Stats Today's Range$0.73▼$0.7650-Day Range$0.63▼$0.8052-Week Range$0.36▼$1.89Volume52,230 shsAverage Volume127,259 shsMarket Capitalization$56.82 millionP/E RatioN/ADividend YieldN/APrice Target$2.00Consensus RatingHold Company Overview Envoy Medical (NASDAQ:COCH) is a medical device company focused on non-invasive neuromodulation therapies for dysphagia, a swallowing disorder that affects patients following neurological events or due to degenerative conditions. The company’s lead technology delivers targeted electrical stimulation designed to strengthen the muscles and neural pathways involved in the swallowing process. Envoy Medical’s flagship therapy has received regulatory clearance from the U.S. Food and Drug Administration and is being introduced through rehabilitation centers, speech-language pathology clinics and acute care hospitals. The company works closely with healthcare providers to integrate its device into patient care pathways, supporting therapy both in clinical environments and at home. Headquartered in the Minneapolis–Saint Paul metropolitan area, Envoy Medical currently serves the U.S. market and is evaluating opportunities for expansion into select international regions. Its leadership team combines expertise in medical device development, rehabilitation sciences and commercial operations, backed by private financing aimed at advancing innovative therapies for neurological and musculoskeletal disorders.AI Generated. May Contain Errors. Read More Envoy Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreCOCH MarketRank™: Envoy Medical scored higher than 50% of companies evaluated by MarketBeat, and ranked 548th out of 918 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingEnvoy Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialEnvoy Medical has a consensus price target of $2.00, representing about 171.7% upside from its current price of $0.74.Amount of Analyst CoverageEnvoy Medical has only been the subject of 2 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Envoy Medical are expected to grow in the coming year, from ($0.31) to ($0.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envoy Medical is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Envoy Medical is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEnvoy Medical has a P/B Ratio of 18.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Envoy Medical's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.21% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 5.58.Change versus previous monthShort interest in Envoy Medical has recently decreased by 11.38%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.59 News SentimentEnvoy Medical has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Envoy Medical this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 3 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have not sold or bought any company stock.Percentage Held by Insiders7.10% of the stock of Envoy Medical is held by insiders.Percentage Held by Institutions8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COCH Stock News HeadlinesHC Wainwright Increases Earnings Estimates for Envoy Medical20 minutes ago | americanbankingnews.comHC Wainwright Lowers Envoy Medical (NASDAQ:COCH) Price Target to $2.00August 23, 2026 | americanbankingnews.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. | Banyan Hill Publishing (Ad)Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for InvestorsAugust 11, 2026 | tipranks.comENVOY MEDICAL INC 0,691 +2,92 %August 10, 2026 | finanznachrichten.deEnvoy Medical Ends ATM Equity Program Amid Capital ConfidenceJune 30, 2026 | tipranks.comEnvoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The StreetJune 4, 2026 | finance.yahoo.comEnvoy Medical Granted Extension to Regain Nasdaq ComplianceMay 22, 2026 | tipranks.comSee More Headlines COCH Stock Analysis - Frequently Asked Questions How have COCH shares performed this year? Envoy Medical's stock was trading at $0.6611 on January 1st, 2026. Since then, COCH stock has increased by 11.3% and is now trading at $0.7360. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Monday, August, 10th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.01. The company earned $0.05 million during the quarter, compared to the consensus estimate of $0.05 million. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envoy Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPENG (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO), CrowdStrike (CRWD) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings8/10/2026Today8/27/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 For the last 10 days, COCH's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:COCH CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Price Target for Envoy Medical$2.00 High Price Target$2.00 Low Price Target$2.00 Potential Upside/Downside+171.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.76 million Net Margins-11,304.83% Pretax Margin-11,304.83% Return on EquityN/A Return on Assets-144.13% Debt Debt-to-Equity RatioN/A Current Ratio1.73 Quick Ratio1.61 Sales & Book Value Annual Sales$240 thousand Price / Sales236.72 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book18.40Miscellaneous Outstanding Shares77,190,000Free Float71,714,000Market Cap$56.81 million OptionableNot Optionable Beta1.90 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:COCH) was last updated on 8/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
